Overexpression of ornithine decarboxylase 1 mediates the immune-deserted microenvironment and poor prognosis in diffuse large B-cell lymphoma

Overexpression of ornithine decarboxylase 1 mediates the immune-deserted microenvironment and poor prognosis in diffuse large B-cell lymphoma

Background: Previous researches mainly focused on whether cancer stem cells exist in diffuse large B-cell lymphoma (DLBCL). However, subgroups with dismal prognosis and stem cell-like characteristics have been overlooked. Methods: Using large scale data (n = 2133), we conducted machine learning algo...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaojie Liang, Jia Guo, Xiaofang Wang, Baiwei Luo, Ruiying Fu, Haiying Chen, Yunong Yang, Zhihao Jin, Chaoran Lin, Aimin Zang, Youchao Jia, Lin Feng, Liang Wang
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Journal of the National Cancer Center
Subjects:	Risk stratification ODC1 Tumor microenvironment Immunotherapy DLBCL
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667005424000875
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Polyamines directly promote antizyme-mediated degradation of ornithine decarboxylase by the proteasome
by: R. Roshini Beenukumar, et al.
Published: (2015-05-01)

A safety catch for ornithine decarboxylase degradation
by: Christof Taxis
Published: (2015-05-01)

Bioinformatics analysis reveals key mechanisms of oligodendrocytes and oligodendrocyte precursor cells regulation in spinal cord Injury
by: Xi Yue, et al.
Published: (2025-02-01)

Structure simulation-based comparison of active site variations in fungal ornithine decarboxylases
by: Min Jeong Kim, et al.
Published: (2025-12-01)

Plasma protein levels and hepatocellular carcinoma: a Mendelian randomization study with drug screening implications
by: Longhui Xie, et al.
Published: (2025-04-01)

A Community Effort to Develop Common Data Elements for Pre-Clinical Spinal Cord Injury Research
by: Britt A. Fedor, et al.
Published: (2025-04-01)

A Community Effort to Develop Common Data Elements for Pre-Clinical Spinal Cord Injury Research
by: Britt A. Fedor, et al.
Published: (2025-01-01)

A case report of vanishing bile duct syndrome and diffuse large b cell lymphoma: An uncommon association
by: Cecilia Anna Fidanza, et al.
Published: (2025-01-01)

Enrichment of ornithine decarboxylase degron transduced colorectal cancer cells for extended application of cancer stem cell models
by: Ryo Ikeshima, et al.
Published: (2025-07-01)

Inhibiting cycloxygenase and ornithine decarboxylase by diclofenac and alpha-difluoromethylornithine blocks cutaneous SCCs by targeting Akt-ERK axis.
by: Aadithya Arumugam, et al.
Published: (2013-01-01)

Ornithine decarboxylase antizyme 2 (OAZ2) in human colon adenocarcinoma: a potent prognostic factor associated with immunity
by: Yiheng Liu, et al.
Published: (2025-03-01)

Toll-like receptor 9 (TLR9) expression correlates with cell of origin and predicts clinical outcome in diffuse large B-cell lymphoma
by: Sulaf Abd Own, et al.
Published: (2025-05-01)

Aberrant Expression and Oncogenic Activity of SPP1 in Hodgkin Lymphoma
by: Stefan Nagel, et al.
Published: (2025-03-01)

A Rare Case of Primary Bone Follicular Lymphoma with Multiple Osteolytic Lesions: A Case Report and Review of the Literature
by: Chiara Togni, et al.
Published: (2024-09-01)

Revealing the heterogeneity of treatment resistance in less‐defined subtype diffuse large B cell lymphoma patients by integrating programmed cell death patterns and liquid biopsy
by: Wei Hua, et al.
Published: (2025-01-01)

Immune signature and pathways investigation of adrenal gland diffuse large B-cell lymphoma
by: Weijing Jia, et al.
Published: (2025-02-01)

Femoral arterial pseudoaneurysm caused by the invasion of diffuse large B-cell lymphoma
by: Makoto Kusakizako, MD, et al.
Published: (2025-08-01)

Nutritional and immune-inflammatory scoring system for predicting outcomes in newly diagnosed diffuse large B-cell lymphoma patients
by: Yu Peng, et al.
Published: (2025-07-01)

THE CORRELATION BETWEEN CELL OF ORIGIN SUBTYPE WITH OVERALL SURVIVAL OF DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS IN KARIADI GENERAL HOSPITAL SEMARANG
by: Jenifer Marsela Tarius, et al.
Published: (2020-05-01)

A case report of surgery-radiotherapy-chemotherapy cured primary diffuse large B-cell lymphoma of the central nervous system associated with HIV infection
by: Qiaoqiao Zhang, et al.
Published: (2024-11-01)

Value of CD5 and CD79 in Evaluation of GIT Lymphoma
by: Huda Mohammed Abdulwahid, et al.
Published: (2025-04-01)

Breast lymphomas: Clinical and pathological insights from a tertiary cancer care center in India
by: Neha Singh, et al.
Published: (2024-12-01)

Prognostic and Differential Diagnostic Value of Standardized Uptake Volume (SUV) of Fluorodeoxyglucose in Patients with Hodgkin’s Lymphoma
by: AA Rukavitsyn, et al.
Published: (2017-04-01)

Peripheral EBV antigen-specific T cell is dysfunctional in Epstein–Barr virus positive diffuse large B-cell lymphoma
by: Liang Gao, et al.
Published: (2025-08-01)

Fusing AVHRR LST With Geostationary SEVIRI LST to Create a Long-Term Daily Maximum LST Time Series Over Europe
by: Philipp Reiners, et al.
Published: (2025-01-01)

Macrophage Membrane-Coated Liposomes Delivering Vonoprazan Disrupt Mitochondrial Oxidative Phosphorylation in Diffuse Large B-Cell Lymphoma
by: Wang W, et al.
Published: (2025-06-01)

Systematic literature review to identify prognostic factors of efficacy and safety outcomes of chimeric antigen receptor T-Cell therapies in diffuse large B-Cell lymphoma
by: Julia K. Schleifenbaum, et al.
Published: (2025-07-01)

Differential expression of proliferation and immune response genes between children and adults influences survival of diffuse large B cell lymphoma
by: Tamara Mangiaterra, et al.
Published: (2025-06-01)

Serum β2-microglobulin level is associated with the survival of HIV-associated diffuse large B-cell lymphoma: a retrospective study from China
by: Xinyi Tang, et al.
Published: (2025-05-01)

Exploration of biomarkers for predicting the prognosis of patients with diffuse large B-cell lymphoma by machine-learning analysis
by: Shifen Wang, et al.
Published: (2025-08-01)

Does CBD induce apoptosis in diffuse large B cell lymphoma?
by: Xu, S.
Published: (2018-08-01)

Surgical Considerations in Treating Central Nervous System Lymphomas: A Case Series of 11 Patients
by: Corneliu Toader, et al.
Published: (2024-10-01)

Case report: From misdiagnosis to timely detection: a clinical and imaging guide to neurological presentations of diffuse large B-cell lymphoma—insights from six cases
by: Chunxiao Yang, et al.
Published: (2025-02-01)

Diffuse large B‐cell lymphoma with BRAFV600E mutation mimicking thyroid carcinoma in fine‐needle aspiration: A diagnostic pitfall
by: Liming Xu, et al.
Published: (2024-09-01)

An interpretable survival model for diffuse large B-cell lymphoma patients using a biologically informed visible neural network
by: Jie Tan, et al.
Published: (2024-12-01)

From Biopsy to Diagnosis: Navigating Aggressive B-Cell Lymphomas in Practice
by: Georgian Halcu, et al.
Published: (2025-05-01)

The single-cell immune landscape of HIV-associated aggressive B-cell lymphoma
by: Xiaomei Zhang, et al.
Published: (2025-04-01)

Raman spectroscopy and bioinformatics-based identification of key genes and pathways capable of distinguishing between diffuse large B cell lymphoma and chronic lymphocytic leukemia
by: Haoyue Liang, et al.
Published: (2025-02-01)

Bilateral Primary Breast Lymphoma Masquerading as Breast Carcinoma: A Rare Case Report
by: Anusheel Anchal Vasnik, et al.

Targeting RPLP2 Triggers DLBCL Ferroptosis by Decreasing FXN Expression
by: Jiaxing Guo, et al.
Published: (2025-05-01)